Overturning the August 21, 2017 verdict that Johnson & Johnson must pay $417 million in compensatory and punitive damages to cancer sufferer Eva Echeverria, a Los Angeles Superior Court judge last week granted a new trial to the pharmaceutical giant, essentially concluding, contra the jury, that Echeverria didn’t adequately demonstrate Johnson & Johnson’s negligence.
Continue reading “Baby Powder, Consumer Labeling and Scientific Uncertainty”
Last month, according to the Los Angeles Times, a court ordered Johnson & Johnson, purveyor of several household health and beauty products, to pay $417 million in damages to Eva Echeverria, a 63-year-old Los Angeles resident who claims the company failed to warn her and other consumers about the cancer risk of their talc-based products, such as their baby powder.
Continue reading “The Reasoning Behind the $417 Million Baby Powder Lawsuit”
Many people were shocked earlier this month when both musician David Bowie and actor Alan Rickman, both 69, died of cancer. Neither obituary stated the type of cancer they died from, as the families chose to keep that information private. However, experts say not disclosing the type of cancer could be detrimental.
Continue reading “The Cancer Stigma in Obituaries”
With October being Breast Cancer Awareness Month, it seems like everywhere we look we’re seeing a wave of pink promotional campaigns. While some see this as a symbol of hope and solidarity for those whose lives have been affected by the disease, others question if buying pink items is really helping the cause.
Continue reading “Should You Think Before You Pink?”
When it comes to medical care, it would make sense to do as the doctors do. As the foremost experts in their fields, doctors’ choices for their own healthcare may be a good indication of ideal treatment options. However, when it comes to terminal illnesses, for an increasing number of physicians, the answer is nothing at all.
Continue reading “The Over-Treatment Paradox”